The ongoing mpox outbreak highlights the urgent need to develop effective therapeutics for endemic and pandemic diseases. There is a need for greater investment and coordination for end-to-end therapeutics development of priority diseases, and equitable access through the value chain must be central to this. This PloS Global Public Health opinion piece makes the case … Continued
– New analysis reveals limited approved tests, treatments and vaccines for WHO priority pathogens, except COVID-19 and Ebola Zaire. – Progress made in vaccines R&D in 2023, but diagnostics and therapeutics underfunded and lagging. – Partners come together in Rome as Italy’s G7 Presidency gets underway to urge leaders to break cycle of ‘panic and … Continued
Two new individuals have been appointed to senior roles within the governance of the 100 Days Mission for pandemic preparedness. Dr Mona Nemer, Chief Science Advisor of Canada, has been appointed Chair of the 100 Days Mission Steering Group, the governing body which oversees the work of the International Pandemic Preparedness Secretariat. Dr Nemer takes … Continued
On Wednesday the 24th of January 2024, the IPPS will host a launch event to explore the findings of the third 100 Days Mission annual implementation report. This report is a ‘pulse check’ for how close the world is to achieving the 100 Days Mission, which outlines the progress made in 2023, the barriers to … Continued
Today, IPPS has released a new Diagnostics Report – ‘Making the Exceptional Routine: embedding diagnostic best practice to improve pandemic preparedness’ in collaboration with FIND, our 100 Days Mission (100DM) diagnostics partners. The report aims to reshape the narrative of pandemic preparedness, highlighting diagnostics as an integral tool for a swift and effective pandemic response. … Continued
Crucial to the success of the 100 Days Mission is its global relevance. As part of our commitment to ensuring the 100DM is widely applicable and beneficial, the IPPS held a series of four regional ‘listening exercises’ over the summer, to better understand different regional contexts and approaches to delivering the 100 Days Mission. Today, … Continued
As the work behind the interim medical countermeasures network (i-MCM-net) progresses, it is essential that it is informed by the lessons from the COVID-19 pandemic. In an opinion piece for The Lancet, the 100 Days Mission Science and Technology Group (STEG) and IPPS Deputy Head of Secretariat set out five recommendations for how this can … Continued
